RecruitingNCT06297993

Global Prospective, Observational Cohort of Adult Patients With Primary Sclerosing Cholangitis (WIND-PSC Study)

A Global Multi-Center Prospective Observational Cohort to Support Drug Development in Adult Patients With Primary Sclerosing Cholangitis (WIND-PSC)

Sponsor

PSC Partners Seeking a Cure

Enrollment

2,000 participants

Start Date

May 6, 2024

Study Type

OBSERVATIONAL

Conditions

PSC

Summary

Develop an appropriate real-world data comparator cohort to support the design, execution, and serve as an external control for interventional clinical trials in PSC.

Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with psc. The study is currently recruiting participants at 18 locations. People eligible for this study include aged 18 Years to 75 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(18)

UC Davis

Sacramento, California, United States

California Pacific Medical Center

San Francisco, California, United States

University of California, San Francisco

San Francisco, California, United States

Yale University

New Haven, Connecticut, United States

Schiff Center for Liver Diseases / University of Miami

Miami, Florida, United States

Indiana University

Indianapolis, Indiana, United States

Massachusetts General Hospital

Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center

Boston, Massachusetts, United States

Mayo Clinic

Rochester, Minnesota, United States

UT Southwestern Medical Center

Dallas, Texas, United States

Virginia Commonwealth University

Richmond, Virginia, United States

University of Alberta

Edmonton, Alberta, Canada

University Health Network

Toronto, Ontario, Canada

Centre de recherche du centre hospitalier de l'Université de Montréal (CRCHUM)

Montreal, Quebec, Canada

University Medical Center Hamburg-Eppendorf

Hamburg, Free and Hanseatic City of Hamburg, Germany

University of Milano Bicocca

Milan, Monza (MB), Italy

Auckland University

Auckland, New Zealand

Oxford University Hospitals

Oxford, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06297993

Related Trials

Pharmacologic Approaches to Preventing Primary Sclerosing Cholangitis Recurrence After Liver Transplantation

NCT069050541 location

Colangioids to Define the Genetic Factors Involved in Atypical Primary Sclerosing Cholangitis

NCT068659241 location

Characterization of Biliary Cell-derived Organoids From Bile of PSC and Non-PSC Patients

NCT047539961 location

Swiss Primary Sclerosing Cholangitis Cohort Study

NCT0314693621 locations

A Microdose Trial Investigating Binding of [68Ga]Ga-DOTA-CYS-ATH001 in Healthy Subjects and Different Patient Groups.

NCT065623613 locations